Judmann, B.; Braun, D.; Wängler, B.; Schirrmacher, R.; Fricker, G.; Wängler, C.
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals 2020, 13, 173.
https://doi.org/10.3390/ph13080173
AMA Style
Judmann B, Braun D, Wängler B, Schirrmacher R, Fricker G, Wängler C.
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals. 2020; 13(8):173.
https://doi.org/10.3390/ph13080173
Chicago/Turabian Style
Judmann, Benedikt, Diana Braun, Björn Wängler, Ralf Schirrmacher, Gert Fricker, and Carmen Wängler.
2020. "Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy" Pharmaceuticals 13, no. 8: 173.
https://doi.org/10.3390/ph13080173
APA Style
Judmann, B., Braun, D., Wängler, B., Schirrmacher, R., Fricker, G., & Wängler, C.
(2020). Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals, 13(8), 173.
https://doi.org/10.3390/ph13080173